Could this Healthcare Stock really climb 1,122.99% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Pharma Stock: 1,788% Upside?]( [Click Here for Symbol.]( --------------------------------------------------------------- March 31, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [FDA news shines light on this little-known clinical-stage Pharma]( Reader, This little-known clinical-stage pharma company recently received a favorable decision from the FDA and it's shining a light on its potential for significant growth. Could we be looking at 1,788% in upside potential? Free report reveals the name, ticker symbol, and 14 reasons to immediately start your research on this company. Don’t miss out on this one... [Click Here For Free Report]( --------------------------------------------------------------- [Targa Resources]( Symbol: [TRGP]( Recent Price: $71.61 Average Analyst Price Target: $100.09 (39.77%) Market Cap: $16.13B Last Year's EPS: $0.06 Consensus EPS Forecast: $1.37 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Tristan Richardson, analyst at Scotiabank, reiterates coverage on [Targa Resources (TRGP)]( in the Utilities sector with a Buy rating and a price target of $115.00 (4 weeks ago). [TipRanks.com]( also reports that [Targa Resources]( currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $100.09. The target pricing ranges from a high forecast of $119.00 down to a low forecast of $87.00. [Targa Resources (TRGP)](’s last closing price was $71.61 which would put the average price target at 39.77% upside. Here are 3rd party ratings for [TRGP](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 17% (43 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Biden To Unleash "Choke Point" Operation On America?]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Science Applications]( Symbol: [SAIC]( Recent Price: $106.68 Average Analyst Price Target: $114.50 (7.33%) Market Cap: $5.83B Last Year's EPS: $1.5 Consensus EPS Forecast: $1.66 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: David E., analyst at Barclays, reiterates coverage on [Science Applications (SAIC)]( in the Technology sector with a Hold rating and a price target of $115.00 (2 months ago). [TipRanks.com]( also reports that [Science Applications]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $114.50. The target pricing ranges from a high forecast of $115.00 down to a low forecast of $114.00. [Science Applications (SAIC)](’s last closing price was $106.68 which would put the average price target at 7.33% upside. Here are 3rd party ratings for [SAIC](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 34% (164 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- [Sutro Biopharma]( Symbol: [STRO]( Recent Price: $4.48 Average Analyst Price Target: $19.50 (335.27%) Market Cap: $274.16M Last Year's EPS: -$0.84 Consensus EPS Forecast: -$0.62 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Derek Archila, analyst at Wells Fargo, reiterates coverage on [Sutro Biopharma (STRO)]( in the Healthcare sector with a Hold rating and a price target of $8.00 (1 week ago). [TipRanks.com]( also reports that [Sutro Biopharma]( currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.50. The target pricing ranges from a high forecast of $26.00 down to a low forecast of $8.00. [Sutro Biopharma (STRO)](’s last closing price was $4.48 which would put the average price target at 335.27% upside. Here are 3rd party ratings for [STRO](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 33% (83 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Shocking Update on Biden's Digital Dollar]( before last Thanksgiving, when nobody was paying attention… Some of the biggest banks in the US launched a pilot program to replace the US dollar in your wallet and bank accounts wiith a new digital dollar. [Click here now and learn how to prepare….]( Because according to an economist ranked #1 by Bloomberg… Those who don’t prepare could soon lose access to your bank account, your credit cards, and even your social security benefits. --------------------------------------------------------------- [Tenax Therapeutics]( Symbol: [TENX]( Recent Price: $0.49 Average Analyst Price Target: $6.00 (1,122.99%) Market Cap: $4.48M Last Year's EPS: -$2.2 Consensus EPS Forecast: -$2.66 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Jonathan Aschoff, analyst at Roth MKM, reiterates coverage on [Tenax Therapeutics (TENX)]( in the Healthcare sector with a Buy rating and a price target of $6.00 (3 weeks ago). [TipRanks.com]( also reports that [Tenax Therapeutics]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00. The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. [Tenax Therapeutics (TENX)](’s last closing price was $0.49 which would put the average price target at 1,122.99% upside. Here are 3rd party ratings for [TENX](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Duck Creek Technologies]( Symbol: [DCT]( Recent Price: $18.99 Average Analyst Price Target: $16.00 (-15.75%) Market Cap: $2.52B Last Year's EPS: $0.04 Consensus EPS Forecast: $0.03 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Peter Heckmann, analyst at D.A. Davidson, reiterates coverage on [Duck Creek Technologies (DCT)]( in the Technology sector with a Hold rating and a price target of $19.00 (1 month ago). [TipRanks.com]( also reports that [Duck Creek Technologies]( currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $16.00. The target pricing ranges from a high forecast of $19.00 down to a low forecast of $11.00. [Duck Creek Technologies (DCT)](’s last closing price was $18.99 which would put the average price target at -15.75% upside. Here are 3rd party ratings for [DCT](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (58 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Plan Could Devastate Your Retirement Savings]( Wall Street insider goes public with the true story of the most harmful action against the wealth of the American people. [See the proof here.]( --------------------------------------------------------------- [Digital Ally]( Symbol: [DGLY]( Recent Price: $3.74 Average Analyst Price Target: $15.00 (300.63%) Market Cap: $10.88M Last Year's EPS: -$2.6 Consensus EPS Forecast: -$2.3 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Michael Albanese, analyst at EF Hutton, reiterates coverage on [Digital Ally (DGLY)]( in the Services sector with a Buy rating and a price target of $15.00 (1 month ago). [TipRanks.com]( also reports that [Digital Ally]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.00. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $15.00. [Digital Ally (DGLY)](’s last closing price was $3.74 which would put the average price target at 300.63% upside. Here are 3rd party ratings for [DGLY](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Precipio]( Symbol: [PRPO]( Recent Price: $0.65 Average Analyst Price Target: $2.85 (341.72%) Market Cap: $14.60M Last Year's EPS: -$0.2 Consensus EPS Forecast: -$0.14 Expected Earnings Date: Apr 03 2023 Recent Analyst Action: Unknown Analyst, analyst at Alliance Global Partners, reiterates coverage on [Precipio (PRPO)]( in the Healthcare sector with a Buy rating and a price target of $2.85 (3 weeks ago). [TipRanks.com]( also reports that [Precipio]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.85. The target pricing ranges from a high forecast of $2.85 down to a low forecast of $2.85. [Precipio (PRPO)](’s last closing price was $0.65 which would put the average price target at 341.72% upside. Here are 3rd party ratings for [PRPO](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Warning: Insiders are going all in on these stocks]( €™s the #1 rule of investing? Follow the money. In other words… Where are the insiders putting their cash? Well guys, I followed the money… And it led me to a little ragtag group of stocks you wouldn’t even know exists. [See what I discovered inside this free report.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software